Susquehanna International Group, LLP Bio N Tech Se Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Bio N Tech Se stock. As of the latest transaction made, Susquehanna International Group, LLP holds 105,009 shares of BNTX stock, worth $10.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
105,009
Previous 6,363
1550.31%
Holding current value
$10.5 Million
Previous $511,000
2340.51%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding BNTX
# of Institutions
358Shares Held
38.4MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.31MShares$828 Million0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$450 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$435 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$189 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$180 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $24.2B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...